Image
Icon
Postpartum Hemorrhage
Icon White
Image
In 2014, the Obstetrical and Gynaecological Society of Malaysia (OGSM) launched an Intensive Course in Obstetric Emergencies (ICOE) – OGSM conducted and supervised a simulation-based course 52 times in 11 countries from 2014 to 2019. During that period, the OGSM trained 1,297 doctors and 136 trainers in the Asia-Oceania region.
Opportunities in Virtual Obstetric Training: lessons from a pilot in China
The Joint statement of recommendation for the use of uterotonics for the prevention of postpartum haemorrhage and the Joint statement of recommendation for the use of tranexamic acid for the treatment of postpartum haemorrhage are the culmination of strong and effective collaboration betw
FIGO and ICM launch joint statements of recommendation for the prevention and treatment of PPH
It is normal for a woman to have bleeding after the birth of her baby. However, when a woman has excessive bleeding after childbirth, this is known as postpartum haemorrhage (PPH). PPH is an obstetric emergency for which immediate interventions are needed to stop bleeding and save the mother. PPH is the leading cause of maternal mortality in low-income countries.
Success stories from FIGO’s Postpartum Haemorrhage projects
Women across the globe are dying unnecessarily due to excessive bleeding after childbirth, in some of the poorest and most under-resourced regions.
- Read more about PPH leading to unnecessary deaths
- Log in to post comments
PPH leading to unnecessary deaths
Noémia Mapasse is currently specialising as an OBGYN in Mozambique and was invited to Brazil as part of the FIGO International Fellowship Programme. She tells us of her experience as a trainee.
- Read more about FIGO Fellowship in Brazil
- Log in to post comments
FIGO Fellowship in Brazil
Guidance on the use of heat-stable carbetocin as an alternative to oxytocin in the prevention of postpartum haemorrhage
The International Federation of Gynecology and Obstetrics (FIGO) and the International Confederation of Midwives (ICM) issued a joint statement on the use of uterotonics to manage and reduce the complications of PPH in July 2021.
Project contact
Rachel Gooden – Project Manager
The activities outlined in this project are supported by funding from Unitaid, innovating for global health.
Accelerating Measurable Progress and Leveraging Investments for Postpartum Haemorrhage Impact (AMPLI-PPHI)
Uterine balloon tamponade for the management of postpartum haemorrhage within health systems
Postpartum haemorrhage (PPH) is a devastating but preventable condition that affects mothers and their children around the world. PPH occurs when a woman has serious bleeding after giving birth. When not treated quickly, it can be fatal. Most deaths from PPH could be avoided through active management of the third stage of labour, and prompt and effective application of the first response bundle (use of uterotonics, uterine massage, fluid replacement and tranexamic acid [TXA]).
Joint statement of recommendation for the use of uterotonics for the prevention of postpartum haemorrhage
Postpartum haemorrhage (PPH) is a devastating but preventable condition that affects mothers and their children around the world. PPH occurs when a mother has serious bleeding after giving birth. When not treated quickly, it can be fatal. Most deaths from PPH could be avoided through active management of the third stage of labour, and prompt and effective application of the first response bundle (use of uterotonics, uterine massage, fluid replacement and tranexamic acid [TXA]).
Joint statement of recommendation for the use of tranexamic acid for the treatment of postpartum haemorrhage
Postpartum haemorrhage (PPH) is a devastating but preventable condition that affects mothers and their children around the world. PPH occurs when a mother has serious bleeding after giving birth. When not treated quickly, it can be fatal. Most deaths from PPH could be avoided through active management of the third stage of laour, and prompt and effective application of the first response bundle (use of uterotonics, uterine massage, fluid replacement and tranexamic acid [TXA]).